Tomorrow's technologies will come from knowledge gained today. This is why the Arizona Heart Institute is an avid supporter of cardiovascular research that enables the medical community to determine whether new treatments are safe and effective for a particular medical condition. At any given time, we are directly involved in the development of exciting new technologies, non-invasive medical devices, revolutionary drug therapies and groundbreaking surgical and interventional techniques. Such research programs have produced results which continue to have a significant impact on the lives of those patients at risk of or suffering from heart and vascular conditions.
The following list summarizes enrolling and upcoming clinical research studies at the Arizona Heart Institute.
ANCHOR - Post market approval registry evaluating aortic aneurysm treatment using an FDA approved device.
BW P4 Obs - Observational Study in a Younger and Older Drug Refractory, Recurrent Symptomatic Paroxysmal AF Population.
CAP 2 (Continued Access to PREVAIL) - Evaluation of Warfarin therapy in atrial fibrillation patients versus left atrial appendage closure technology.
ChocolateTM Balloon Angioplasty Registry (BAR) - An observational Study collecting data on commercial cases in which Chocolate PTA balloon catheter is used as primary treatment.
EASE - A prospective, multicenter clinical evaluation of the safety and effectiveness of an atherectomy device in atherectomy of the peripheral vasculature.
ENDOFORM - Prospective, multicenter clinical evaluation of the safety and effectiveness of extracellular matrix dressing in the treatment of chronic venous leg ulcers.
EXCITE - Randomized controlled study for treatment of femoropopliteal instent restenosis.
FREEDOM - Flow Reversal System and Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes.
FS Grifols - A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant as an Adjunct to Hemostasis during Peripheral Vascular Surgery.
FSS OPEN - Evaluation of safety and efficacy of a femoropopliteal stent system.
INPACT SFA - Randomized Trial of a Drug-Eluting Balloon (DEB) vs Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA).
INSPIRATION - A Multicenter, Open Label, Prospective, Non-Randomized Study Of a Stent Graft System In Subjects With Abdominal Aortic Aneurysms.
Jetstream G3 - Post market registry to investigate the treatment effects with the Jetstream G3 System in moderate to severely calcified peripheral artery disease in the common femoral, superficial femoral or popliteal arteries using IVUS.
MADIT RIT - Post market approval registry for an automatic defibrillator implantation trial.
QuickFlex - Post market approval registry of left heart pacing lead.
RELAY - A phase II clinical study of the safety and efficacy of a thoracic stent graft in patients with thoracic aortic pathologies.
RENEW - A prospective, randomized, double-blinded, active-control, and unblinded standard of care (SOC) controlled study to determine the safety and effectiveness of an investigational therapy using a patient's own stem cells for the treatment of angina. Visit Renew Study to learn more.
REVIVE - A multicenter, randomized, double-blind, placebo-controlled, parallel group clinical trial evaluating a patient specific investigational cellular therapy to see if it can promote healing and tissue regeneration for patients with critical limb ischemia.
SCORE - Post market approval registry of patients implanted with SJM market-released CRM products.
VENTANA Study - Prospective, Multicenter, Single Arm Safety and Effectiveness Trial of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms. Learn More.
New studies are open regularly, please call 602-604-5270 for information on upcoming studies.